1. Home
  2. List
Reference Patent

Reference - List

When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 28 Hits
  • Search Condition : Filter (MeSH = Prostatic Neoplasms / pathology)
Species Resource Title
Human and Animal Cells LNCap.FGC(RCB2144) Functional upregulation of the H2S/Cav3.2 channel pathway accelerates secretory function in neuroendocrine-differentiated human prostate cancer cells.
DNA material CSII-CMV-MCS-IRES2-Bsd (RDB04385) , pCAG-HIVgp (RDB04394) , pCMV-VSV-G-RSV-Rev (RDB04393) SPOP is essential for DNA-protein cross-link repair in prostate cancer cells: SPOP-dependent removal of topoisomerase 2A from the topoisomerase 2A-DNA cleavage complex.
Human and Animal Cells PC-3(RCB2145) Altered miRNA expression in high-fat diet-induced prostate cancer progression.
Human and Animal Cells MC3T3-E1(RCB1126) Biologic mechanisms of 89SrCl2 incorporation into type I collagen during bone mineralization.
Human and Animal Cells LNCap.FGC(RCB2144) Impact of 18F-PSMA-1007 Uptake in Prostate Cancer Using Different Peptide Concentrations: Preclinical PET/CT Study on Mice.
Human and Animal Cells PC-3(RCB2145) , HL-60(RCB3683) , LNCap.FGC(RCB2144) Blockade of γ-Glutamylcyclotransferase Enhances Docetaxel Growth Inhibition of Prostate Cancer Cells.
Human and Animal Cells PC-3(RCB2145) Correlation between DEC1/DEC2 and epithelial‑mesenchymal transition in human prostate cancer PC‑3 cells.
Human and Animal Cells PC-3(RCB2145) Galectin-9 induces atypical ubiquitination leading to cell death in PC-3 prostate cancer cells.
Human and Animal Cells LNCap.FGC(RCB2144) Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer.
Human and Animal Cells LNCap.FGC(RCB2144) Hyperactive mTOR induces neuroendocrine differentiation in prostate cancer cell with concurrent up-regulation of IRF1.
Human and Animal Cells LNCap.FGC(RCB2144) Hollow boron nitride nanospheres as boron reservoir for prostate cancer treatment.
Human and Animal Cells DU145(RCB2143) Lapatinib-resistant cancer cells possessing epithelial cancer stem cell properties develop sensitivity during sphere formation by activation of the ErbB/AKT/cyclin D2 pathway.
Human and Animal Cells LNCap.FGC(RCB2144) Docetaxel induces Bcl-2- and pro-apoptotic caspase-independent death of human prostate cancer DU145 cells.
C.elegans tm3976 Identification of a genetic interaction between the tumor suppressor EAF2 and the retinoblastoma protein (Rb) signaling pathway in C. elegans and prostate cancer cells.
C.elegans tm3976 FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells.
Human and Animal Cells Eph receptor A10 has a potential as a target for a prostate cancer therapy.
Human and Animal Cells Hedgehog/GLI-mediated transcriptional inhibitors from Zizyphus cambodiana.
Human and Animal Cells Potent anticancer activities of novel aminophenol analogues against various cancer cell lines.
Human and Animal Cells SQ-5(RCB0110) Inhibition of homologous recombination repair in irradiated tumor cells pretreated with Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin.
Human and Animal Cells Novel HER2 selective tyrosine kinase inhibitor, TAK-165, inhibits bladder, kidney and androgen-independent prostate cancer in vitro and in vivo.